With the advent of the genome projects, both human and pathogen, our whole approach to studying the role of hostlpathogen interactions in determining infectious disease sus ceptibility has undergone a remarkable transformation.
The first impact that modem genornics had on analysing genetic susceptibility to infec tion was the ability to use physical mapping data and 'big DNA' (yeast and bacterial artifi cial chromosomes, cosrnids) clone contigs to pinpoint a gene and identify it on the basis of its genetic map location. The first elegant example of this was the positional cloning 1 of the murine natural resistance associated macrophage protein I (Nrampl) gene, variously known in earlier studies as lty, Lsh and Bcg for its role in controlling innate resistance and susceptibility to Salmonella typhimurium, Leishmania donovani or My cobacterium bovis BCG infection, respectively. In this case, ability to clone the gene on the basis of its map location was vitalIy dependent on the ability to 'genotype' individual rnice according to their phenotypic response to infection. For alI three infections (e.g. reference 2 ), segregation of disease phenotypes in the F2 and backcross progeny made between resistant and suscept ible inbred mouse strains fOlIowed perfect Mendelian inheritance, with resistance almost complete1y dorninant and individual rnice falling clearly into non-overlapping resistant or susceptible phenotypes on the basis of liver or spleen pathogen counts. The identification of lty/Lsh/Bcg gene was highly relevant to human disease susceptibility, since we had alI been anxious to know whether a human homologue would also control susceptibility to leprosy anel/or tuberculosis. In humans, NRAMPl is globally linked or associated with tuberculosis 3 -8 and is also linked to leprosy susceptibility 9 and ability to mount a Mitsuda type skin test reaction to leprosy antigens 10 in Vietnam. These studies provided strong support for the concept that murine models of disease can identify disease susceptibility genes that will be important in humans.
The Vidal study\ was a model of perfection for its time. It involved extensive studies using exon trapping and analysis of tissue expression profiles of candidate exons/genes within the narrowed down interval known to contain the gene in order finalIY to identify the macrophage-expressed Nramp I protein, now renamed solute carrier farnily lIa member I (SlcllaI) on the basis of its function as a divalent cationlproton antiporter. \\ Now that the first draft of the human sequence is published, 1 2 . 13 we should be able directly to identify the chromosome linked to susceptibility to infection in humans and simply inspect the region under the linkage curve to identify the disease-associated gene. Or is it realIy that simple?
The first example of direct identification of a human infectious disease susceptibility gene using modem genornics was another very elegant study in which egg output for schistosomiasis was measured in large multicase pedigrees in Brazil and shown to segregate as a Mendelian single gene trait. 14 DNAs from a subset of 11 informative complex multi case pedigrees was used in a 10-15 centimorgan (cM) rnicrosatellite genome scan, i.e. the DNA for 142 individuaIs in these pedigrees were genotyped for �300 rnicrosatellite markers across the genome, and multipoint linkage analyses performed to locate the single major gene that had been predicted. Luckily, on1y a single maj or linkage peak was identi fied with a peak parametric lod score (log likelihood for linkage) of 4·74 (i.e. > 10,000: 1 odds in favour of linkage). However, although the peak lod score was found near the locus containing the gene (CSFIR) encoding the receptor for colony stimulating factor 1, the linked region contained a host of other potential candidate genes inc1uding those encoding inter leukin (ll... ) 4, ll... 5, ll... 9, ll... 13, and interferon regulatory factor 1 (IRFl), for alI of which a plausible case could be built for their involvement in deterrnining susceptibility to schisto some infection. Unfortunately, the ability to fine map the region and pinpoint the real susceptibility gene relies on much larger samples sizes and linkage disequilibrium mapping, and such studies are even now still in progresso
The second published attempt at mapping infectious disease susceptibility genes via a genome scan was for tuberculosis, this time using non-parametric linkage analysis of affected sibling pairs. 15 lnitialIy, 92 affected sibling pairs plus parents colIected from The Gambia and South Africa were genotyped for 299 rnicrosatelIite markers. Seven regions of the genome showed maximum lod scores (MLS) >1 (P = 0·05). Twenty-two markers from these regions were typed in a second set of 82 affected sibling pairs plus parents, with on1y chromosomes 15q (MLS = 2) and Xq (MLS = 1 · 77) retaining lod scores suggestive of linkage but this time at odds :5100: 1. This does not achieve the leveIs of significance recommended for a genome-wide scan, 1 6 probably reflecting the fact that this sample size is not sufficient to detect linkage for genes contributing to the complex disease phenotype of pulmonary tuberculosis. It is likely that the search for susceptibility genes for tubercu losis wilI require much larger sample sizes, and much more effort, to identify the multiple genes that are likely to be contributing to overalI disease susceptibility.
The third published example of genome scanning to identify susceptibility genes for infectious disease is the recently reported study on leprosy. 17 In this case, the authors were more successful in ultimately identifying a region on chromosome lOp13 with a non parametric MLS of 4.09 (P = 0·000007) (Figure 1) . To obtain this, 388 markers were ini tially typed on 103 affected sibling pairs plus parents. Twenty-eight regions were identified with MLS >1·0. Thirty-seven markers from these regions were typed in an additional 142 affected sibling pair farnilies. In the overall analysis, only chromosome lOp13 showed a multipoint MLS >3·0. A further eight markers typed in this region yielded the final MLS of 4·09. Exarnination of public domain databases provides a single obvious candidate, the gene encoding mannose receptor C type 1 (MRC l), that maps under the lOp13 interval 18 positive for linkage to leprosy susceptibility. Recent studies 1 9 provide new structural insights into the molecular deciphering of mycobacterial lipoglycan binding to C-type lectins such as the macrophage mannose receptor, providing a rational basis to target MRC 1 as the most appropriate candidate within the linkage interval on lOp13. Polymorphisms within the MRC l gene are now being analysed in allelic association studies. The maximum multipoint MLS for the region is 4·09 (P value = 0·000007) and corresponded to DlOS166. Reproduced with permission from Siddiqui et ai. 17 The results of this Indian study are interesting in relation to previous studies suggesting a role for HLA in detennining leprosy susceptibility, including many studies based in India. In the genome scan, markers within HLA were not positive for linkage. Hence, the authors conclude that HLA is not a major susceptibility gene in India. 1 7 In our own studies of leprosy in Brazil, we have found a peak parametric lod score for linkage to HLA of 5·78 (P = 0·00000025) in 73 two and three generation extended multicase pedigrees analysed using combined segregation and linkage analysis, 20 similar to that used in the schistosomiasis study. Affected sib pair analysis of the same farnilies for 63 nuclear families with 138 affected sibling pairs (equivalent to 91 affected sib pairs plus parents after weighting for multiple affected sib pairs in a farnily) provides an MLS of only 2· 12 (P = 0·002), demonstrating the increased power provided by the larger two and three generation pedigrees. Nevertheless, the locus-specific risk for siblings of patients (Às) for the peak of linkage at HLA (calculated from the ratio of the expected proportion of affected sibling pairs sharing zero alleles identical by descent (0·25) and the observed proportion 2 l ) based on this set of affected sibling pairs is 1·79, compared to a value of 1·66 for the peak of linkage on chromosome lOp13 in the Indian study (245 independent affected sibling pairs l 7 ). Hence, we may conclude that HLA makes an equivalent if not greater contribution to the total genetic component of susceptibility to leprosy per se in Brazil as the chromosome lOp13 gene does in India, highlighting the fact that different genes may contribute to disease susceptibility in different geographic regions. Alternatively, or in addition, the Indian study took place in an area where the incidence of paucibacillary leprosy was high and none of the families had only multibacillary affected siblings, whereas the Brazilian study took place in an area with high incidence of multibacillary leprosy. Interestingly, detailed investigation of HLA in a similar samp1e of 98 multicase pedigrees with pulmonary tuberculosis from the same region of Brazil failed to show any evidence for linkage or allelic association (I. Davidson, J. M. Blackwell & M.-A. Shaw, unpublished observation). For 1eprosy, allelic association was highly significant in both the HLA DRlDQ (P = 0·001-0·024) and TNFA (P = 3·6 x 10-5 ) gene regions. 20 Hence, these two important mycobacterial infections of humans show quite distinct genetic regulation, particularly with respect to the role of the major histocom patibility complex in this region of Brazil.
So what can we learn from these new genome-based family studies of susceptibility to infectious disease? Firstly, two of the three studies performed to date have identified major genes controlling disease susceptibility that conform to the genome-wide criteria for statistically significant linkage. 1 6 In both cases, obvious candidate genes have been identi fied under the region of linkage. For schistosomiasis, a candidate rich region was identified, which has made it difficult to identify the specific gene regulating egg output. For leprosy, there appears at present to be just one obvious candidate (MRC l) under the linked region in India, but confirmation of its role has yet to be published and its global relevance to leprosy susceptibility requires further investigation. For tuberculosis, genetic regulation appears more complex, and will require further work to uncover the multiple genes and mechanisms likely to regulate susceptibility. As for schistosomiasis, this might involve careful stratifi cation of the disease phenotype, with better recording of clinicai criteria across the spectrum of disease. The same is true for leprosy, where the studies in both India and Brazil have focussed on areas differing in incidence of paucibacillary versus multibacillary leprosy. Nevertheless, these ground-breaking studies applying modem whole-genome approaches to infectious disease susceptibility promise to yield rich rewards in furthering our understanding of the genes and mechanisms that regulate infectious disease susceptibility.
